- Home
- EQT vs BNTX Comparison
EQT vs BNTX Comparison
Compare EQT & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQT
- BNTX
- Stock Information
- Founded
- EQT 1925
- BNTX 2008
- Country
- EQT United States
- BNTX Germany
- Employees
- EQT N/A
- BNTX N/A
- Industry
- EQT Oil & Gas Production
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EQT Energy
- BNTX Health Care
- Exchange
- EQT Nasdaq
- BNTX Nasdaq
- Market Cap
- EQT 26.5B
- BNTX 23.9B
- IPO Year
- EQT N/A
- BNTX 2019
- Fundamental
- Price
- EQT $42.97
- BNTX $113.08
- Analyst Decision
- EQT Buy
- BNTX Strong Buy
- Analyst Count
- EQT 18
- BNTX 15
- Target Price
- EQT $45.41
- BNTX $143.50
- AVG Volume (30 Days)
- EQT 7.7M
- BNTX 790.2K
- Earning Date
- EQT 02-11-2025
- BNTX 11-04-2024
- Dividend Yield
- EQT 1.49%
- BNTX N/A
- EPS Growth
- EQT N/A
- BNTX N/A
- EPS
- EQT 0.67
- BNTX N/A
- Revenue
- EQT $4,623,048,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- EQT $14.05
- BNTX N/A
- Revenue Next Year
- EQT $35.73
- BNTX N/A
- P/E Ratio
- EQT $64.20
- BNTX N/A
- Revenue Growth
- EQT N/A
- BNTX N/A
- 52 Week Low
- EQT $30.02
- BNTX $76.53
- 52 Week High
- EQT $48.02
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- EQT 47.18
- BNTX 47.60
- Support Level
- EQT $42.27
- BNTX $109.52
- Resistance Level
- EQT $46.31
- BNTX $123.30
- Average True Range (ATR)
- EQT 1.24
- BNTX 4.88
- MACD
- EQT -0.48
- BNTX -0.94
- Stochastic Oscillator
- EQT 17.33
- BNTX 22.42
About EQT EQT Corporation
EQT Corp is an independent natural gas production company with operations focused in the Marcellus and Utica shale plays in the Appalachian Basin. At year-end 2023, EQT's proven reserves totaled 27.6 trillion cubic feet equivalent, with net production of 5.79 billion cubic feet equivalent per day. Natural gas accounted for 94% of production.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.